Related Experiment Video

Updated: Aug 11, 2026

Establishment and Optimization of a High Throughput Setup to Study Staphylococcus epidermidis and Mycobacterium marinum Infection as a Model for Drug Discovery
10:19

Establishment and Optimization of a High Throughput Setup to Study Staphylococcus epidermidis and Mycobacterium marinum Infection as a Model for Drug Discovery

Published on: June 26, 2014

Rifamycins: strain improvement program

R Lal1, M Khanna, H Kaur

  • 1Department of Zoology, University of Delhi.

Critical Reviews in Microbiology
|January 1, 1995
PubMed

Insights

Amycolatopsis mediterranei produces important rifamycin antibiotics. Genetic manipulation of this bacterium, including recombinant DNA techniques, has been crucial for improving antibiotic yields and developing new derivatives.

Area of Science:

  • Microbiology
  • Antibiotic Discovery
  • Genetic Engineering

Background:

  • Rifamycins are crucial antibiotics produced by Amycolatopsis mediterranei.
  • These antibiotics are vital for treating tuberculosis, leprosy, and other bacterial infections.
  • Strain improvement of A. mediterranei has been pursued since 1957 to enhance rifamycin production.

Purpose of the Study:

  • To review the genetic manipulation strategies for Amycolatopsis mediterranei.
  • To discuss traditional strain improvement methods and their limitations.
  • To highlight the advent of recombinant DNA techniques for A. mediterranei.

Main Methods:

  • Review of historical strain improvement techniques (mutations, recombination).
  • Discussion of the development of cloning vectors for A. mediterranei.
  • Explanation of transformation methods enabling genetic manipulation.

Main Results:

  • Traditional methods have limitations in optimizing rifamycin production.
  • Development of cloning vectors and transformation methods has enabled advanced genetic engineering.
  • Recombinant DNA techniques provide powerful tools for A. mediterranei strain development.

Conclusions:

  • Genetic manipulation of Amycolatopsis mediterranei is essential for antibiotic production.
  • Recombinant DNA technology has significantly advanced the potential for rifamycin improvement.
  • Continued genetic engineering efforts are key to developing superior rifamycin-producing strains.

More Related Videos

Antibiotic Dereplication Using the Antibiotic Resistance Platform10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...